Presage Biosciences

Presage’s patented CIVO® (Comparative In Vivo Oncology) technology delivers microdoses of multiple drugs to different regions of a tumor, while the tumor is still in the patient. Source (opens in a new tab)

Headquarters

US

Provider types

CRO, clinical CRO